Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
PATH vs APPN vs PEGA vs NICE vs NOW
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Application
Software - Application
Software - Application
PATH vs APPN vs PEGA vs NICE vs NOW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Infrastructure | Software - Application | Software - Application | Software - Application |
| Market Cap | $5.99B | $1.68B | $6.25B | $7.72B | $95.34B |
| Revenue (TTM) | $1.61B | $691M | $1.70B | $2.95B | $13.96B |
| Net Income (TTM) | $282M | $-7M | $341M | $613M | $1.76B |
| Gross Margin | 83.2% | 76.3% | 75.0% | 66.4% | 76.6% |
| Operating Margin | 3.5% | 0.9% | 10.2% | 21.9% | 13.4% |
| Forward P/E | 15.9x | 25.6x | 13.6x | 11.4x | 22.1x |
| Total Debt | $71M | $290M | $76M | $164M | $3.20B |
| Cash & Equiv. | $871M | $136M | $212M | $379M | $3.73B |
PATH vs APPN vs PEGA vs NICE vs NOW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| UiPath Inc. (PATH) | 100 | 14.9 | -85.1% |
| Appian Corporation (APPN) | 100 | 18.7 | -81.3% |
| Pegasystems Inc. (PEGA) | 100 | 58.2 | -41.8% |
| NICE Ltd. (NICE) | 100 | 51.8 | -48.2% |
| ServiceNow, Inc. (NOW) | 100 | 18.2 | -81.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PATH vs APPN vs PEGA vs NICE vs NOW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PATH ranks third and is worth considering specifically for momentum.
- -9.1% vs NOW's -90.6%
APPN is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 0.81
PEGA is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 189.1% 10Y total return vs NICE's 96.6%
- 0.2% yield; 1-year raise streak; the other 4 pay no meaningful dividend
- 23.5% ROA vs APPN's -1.2%, ROIC 27.2% vs 0.3%
NICE carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.72, Low D/E 4.2%, current ratio 1.55x
- Beta 0.72, current ratio 1.55x
- Lower P/E (11.4x vs 13.6x)
- 20.8% margin vs APPN's -1.1%
NOW is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 20.9%, EPS growth 21.9%, 3Y rev CAGR 22.4%
- PEG 0.32 vs NICE's 0.43
- 20.9% revenue growth vs NICE's 8.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.9% revenue growth vs NICE's 8.5% | |
| Value | Lower P/E (11.4x vs 13.6x) | |
| Quality / Margins | 20.8% margin vs APPN's -1.1% | |
| Stability / Safety | Beta 0.72 vs NOW's 1.46, lower leverage | |
| Dividends | 0.2% yield; 1-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | -9.1% vs NOW's -90.6% | |
| Efficiency (ROA) | 23.5% ROA vs APPN's -1.2%, ROIC 27.2% vs 0.3% |
PATH vs APPN vs PEGA vs NICE vs NOW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PATH vs APPN vs PEGA vs NICE vs NOW — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NICE leads in 2 of 6 categories
PEGA leads 2 • PATH leads 0 • APPN leads 0 • NOW leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — NICE and NOW each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NOW is the larger business by revenue, generating $14.0B annually — 20.2x APPN's $691M. NICE is the more profitable business, keeping 20.8% of every revenue dollar as net income compared to APPN's -1.1%. On growth, NOW holds the edge at +22.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.6B | $691M | $1.7B | $3.0B | $14.0B |
| EBITDAEarnings before interest/tax | $74M | $16M | $193M | $846M | $2.7B |
| Net IncomeAfter-tax profit | $282M | -$7M | $341M | $613M | $1.8B |
| Free Cash FlowCash after capex | $352M | $73M | $495M | $665M | $4.6B |
| Gross MarginGross profit ÷ Revenue | +83.2% | +76.3% | +75.0% | +66.4% | +76.6% |
| Operating MarginEBIT ÷ Revenue | +3.5% | +0.9% | +10.2% | +21.9% | +13.4% |
| Net MarginNet income ÷ Revenue | +17.5% | -1.1% | +20.0% | +20.8% | +12.6% |
| FCF MarginFCF ÷ Revenue | +21.9% | +10.5% | +29.1% | +22.5% | +33.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.6% | +21.4% | -9.6% | +9.7% | +22.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +111.1% | +4.4% | -60.0% | +57.8% | +2.3% |
Valuation Metrics
NICE leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 12.8x trailing earnings, NICE trades at a 99% valuation discount to APPN's 1136.0x P/E. Adjusting for growth (PEG ratio), NICE offers better value at 0.48x vs NOW's 0.79x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6.0B | $1.7B | $6.2B | $7.7B | $95.3B |
| Enterprise ValueMkt cap + debt − cash | $5.2B | $1.8B | $6.1B | $7.5B | $94.8B |
| Trailing P/EPrice ÷ TTM EPS | 20.58x | 1136.00x | 17.35x | 12.82x | 55.10x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.89x | 25.57x | 13.60x | 11.42x | 22.13x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.48x | 0.79x |
| EV / EBITDAEnterprise value multiple | 66.62x | 3014.08x | 21.14x | 8.72x | 37.01x |
| Price / SalesMarket cap ÷ Revenue | 3.72x | 2.31x | 3.58x | 2.60x | 7.18x |
| Price / BookPrice ÷ Book value/share | 2.80x | — | 8.67x | 2.04x | 7.43x |
| Price / FCFMarket cap ÷ FCF | 17.01x | 28.23x | 12.73x | 10.98x | 20.83x |
Profitability & Efficiency
PEGA leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
PEGA delivers a 50.2% return on equity — every $100 of shareholder capital generates $50 in annual profit, vs $15 for NOW. PATH carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to NOW's 0.25x. On the Piotroski fundamental quality scale (0–9), PATH scores 8/9 vs NOW's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.3% | — | +50.2% | +15.8% | +15.0% |
| ROA (TTM)Return on assets | +10.0% | -1.2% | +23.5% | +12.0% | +7.5% |
| ROICReturn on invested capital | +3.9% | +0.3% | +27.2% | +13.5% | +12.4% |
| ROCEReturn on capital employed | +2.8% | +0.2% | +33.4% | +16.4% | +13.2% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 | 8 | 7 | 3 |
| Debt / EquityFinancial leverage | 0.03x | — | 0.10x | 0.04x | 0.25x |
| Net DebtTotal debt minus cash | -$800M | $154M | -$136M | -$216M | -$523M |
| Cash & Equiv.Liquid assets | $871M | $136M | $212M | $379M | $3.7B |
| Total DebtShort + long-term debt | $71M | $290M | $76M | $164M | $3.2B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.85x | 643.17x | — | 185.08x |
Total Returns (Dividends Reinvested)
PEGA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PEGA five years ago would be worth $6,321 today (with dividends reinvested), compared to $1,510 for PATH. Over the past 12 months, PATH leads with a -9.1% total return vs NOW's -90.6%. The 3-year compound annual growth rate (CAGR) favors PEGA at 20.8% vs NOW's -40.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -32.6% | -33.3% | -34.0% | +11.7% | -37.6% |
| 1-Year ReturnPast 12 months | -9.1% | -26.7% | -20.1% | -20.9% | -90.6% |
| 3-Year ReturnCumulative with dividends | -16.9% | -33.1% | +76.1% | -33.2% | -78.8% |
| 5-Year ReturnCumulative with dividends | -84.9% | -77.8% | -36.8% | -47.0% | -80.8% |
| 10-Year ReturnCumulative with dividends | -84.5% | +51.4% | +189.1% | +96.6% | +35.7% |
| CAGR (3Y)Annualised 3-year return | -6.0% | -12.5% | +20.8% | -12.6% | -40.4% |
Risk & Volatility
NICE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NICE is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than NOW's 1.46 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NICE currently trades 69.2% from its 52-week high vs NOW's 8.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.34x | 0.81x | 1.16x | 0.72x | 1.46x |
| 52-Week HighHighest price in past year | $19.84 | $46.06 | $68.10 | $180.61 | $1057.39 |
| 52-Week LowLowest price in past year | $9.28 | $19.79 | $34.34 | $94.89 | $81.24 |
| % of 52W HighCurrent price vs 52-week peak | +53.9% | +49.3% | +54.3% | +69.2% | +8.7% |
| RSI (14)Momentum oscillator 0–100 | 51.9 | 50.3 | 39.9 | 70.6 | 44.8 |
| Avg Volume (50D)Average daily shares traded | 30.9M | 781K | 2.2M | 588K | 20.8M |
Analyst Outlook
Evenly matched — APPN and PEGA each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: PATH as "Hold", APPN as "Hold", PEGA as "Buy", NICE as "Buy", NOW as "Buy". Consensus price targets imply 64.7% upside for NOW (target: $152) vs 20.7% for NICE (target: $151). PEGA is the only dividend payer here at 0.23% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $15.82 | $31.25 | $56.60 | $150.88 | $151.52 |
| # AnalystsCovering analysts | 24 | 19 | 23 | 23 | 68 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.2% | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | 1 | 0 | — |
| Dividend / ShareAnnual DPS | — | — | $0.08 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.5% | +1.2% | +8.3% | +6.4% | +1.9% |
NICE leads in 2 of 6 categories (Valuation Metrics, Risk & Volatility). PEGA leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
PATH vs APPN vs PEGA vs NICE vs NOW: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PATH or APPN or PEGA or NICE or NOW a better buy right now?
For growth investors, ServiceNow, Inc.
(NOW) is the stronger pick with 20. 9% revenue growth year-over-year, versus 8. 5% for NICE Ltd. (NICE). NICE Ltd. (NICE) offers the better valuation at 12. 8x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Pegasystems Inc. (PEGA) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PATH or APPN or PEGA or NICE or NOW?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 12. 8x versus Appian Corporation at 1136. 0x. On forward P/E, NICE Ltd. is actually cheaper at 11. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ServiceNow, Inc. wins at 0. 32x versus NICE Ltd. 's 0. 43x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PATH or APPN or PEGA or NICE or NOW?
Over the past 5 years, Pegasystems Inc.
(PEGA) delivered a total return of -36. 8%, compared to -84. 9% for UiPath Inc. (PATH). Over 10 years, the gap is even starker: PEGA returned +189. 1% versus PATH's -84. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PATH or APPN or PEGA or NICE or NOW?
By beta (market sensitivity over 5 years), NICE Ltd.
(NICE) is the lower-risk stock at 0. 72β versus ServiceNow, Inc. 's 1. 46β — meaning NOW is approximately 102% more volatile than NICE relative to the S&P 500. On balance sheet safety, UiPath Inc. (PATH) carries a lower debt/equity ratio of 3% versus 25% for ServiceNow, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PATH or APPN or PEGA or NICE or NOW?
By revenue growth (latest reported year), ServiceNow, Inc.
(NOW) is pulling ahead at 20. 9% versus 8. 5% for NICE Ltd. (NICE). On earnings-per-share growth, the picture is similar: UiPath Inc. grew EPS 500. 0% year-over-year, compared to 21. 9% for ServiceNow, Inc.. Over a 3-year CAGR, NOW leads at 22. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PATH or APPN or PEGA or NICE or NOW?
Pegasystems Inc.
(PEGA) is the more profitable company, earning 22. 5% net margin versus 0. 2% for Appian Corporation — meaning it keeps 22. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 22. 2% versus 0. 1% for APPN. At the gross margin level — before operating expenses — PATH leads at 83. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PATH or APPN or PEGA or NICE or NOW more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ServiceNow, Inc. (NOW) is the more undervalued stock at a PEG of 0. 32x versus NICE Ltd. 's 0. 43x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NICE Ltd. (NICE) trades at 11. 4x forward P/E versus 25. 6x for Appian Corporation — 14. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NOW: 64. 7% to $151. 52.
08Which pays a better dividend — PATH or APPN or PEGA or NICE or NOW?
In this comparison, PEGA (0.
2% yield) pays a dividend. PATH, APPN, NICE, NOW do not pay a meaningful dividend and should not be held primarily for income.
09Is PATH or APPN or PEGA or NICE or NOW better for a retirement portfolio?
For long-horizon retirement investors, NICE Ltd.
(NICE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72)). Both have compounded well over 10 years (NICE: +96. 6%, NOW: +35. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PATH and APPN and PEGA and NICE and NOW?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PATH is a small-cap quality compounder stock; APPN is a small-cap high-growth stock; PEGA is a small-cap high-growth stock; NICE is a small-cap deep-value stock; NOW is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.